Cornercap Investment Counsel’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Cornercap Investment Counsel's DGX Position: Q2 2024 in Review
Cornercap Investment Counsel sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 6,769 shares — an estimated $901K sold.
Cornercap Investment Counsel first reported a position in DGX in Q1 2015 and held it in 21 quarters. The position peaked at $4.14M in Q3 2018. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.
- Cornercap Investment Counsel reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
- Cornercap Investment Counsel sold 6,769 Quest Diagnostics shares in Q2 2024, an estimated $901K.
- Cornercap Investment Counsel first reported a position in Quest Diagnostics in Q1 2015 and held it in 21 quarters.
- Cornercap Investment Counsel's Quest Diagnostics position peaked at $4.14M in Q3 2018.
- 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.
Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.